explore -WSS

explore

author：explore 2025-09-30 23:19:16 - browse：4

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Information blocking fines are now fair game in health care

entertainment

WSS

Eli Lilly CEO gives to Mike Pence presidential super PAC

Roche subsidiary Foundation Medicine opens new headquarters

Supreme Court mifepristone arguments center on docs' right to sue

Study says nonprofit hospitals fall short in charity care spending

Transgender sports debate: Physicians say bans are health issue

Readout Newsletter: Merck, Vertex, and Viking updates

explore

explore

hotspot

Bright Health sells Medicare Advantage business to Molina

Chamber of Commerce, DOJ clash in court over drug prices

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Eliminate the waiting period for sterilization covered by Medicaid

Hepatitis C has a cure — but many Americans still lack access to it

Transgender sports debate: Physicians say bans are health issue

Cancer drug shortages should be causing more outrage

Washington mulls new rules to avert another Change Healthcare

Wildfire smoke exposes gaps in outdoor worker protections

FDA weighs limits of animal data in assessing artificial wombs

knowledge

Transgender sports debate: Physicians say bans are health issue

Chamber of Commerce, DOJ clash in court over drug prices

Steward Health Care has deal to sell doctor network to UnitedHealth

There's no autism epidemic. It's an autism diagnosis epidemic

Akili changes sales model for its ADHD video game treatment

Abortion pill Supreme Court ruling could impact entire drug industry

entertainment

leisure time

explore

knowledge